Display options
Cite
Eugene AR, Masiak J, Kapica J, et al. Electrophysiological Neuroimaging using sLORETA Comparing 22 Age Matched Male and Female Schizophrenia Patients. Hosp Chron. 2015;10(2):91-98
Eugene, A. R., Masiak, J., Kapica, J., Masiak, M., & Weinshilboum, R. M. (2015). Electrophysiological Neuroimaging using sLORETA Comparing 22 Age Matched Male and Female Schizophrenia Patients. Hospital chronicles = Nosokomeiaka chronika, 10(2), 91-98.
Eugene, Andy R, et al. "Electrophysiological Neuroimaging using sLORETA Comparing 22 Age Matched Male and Female Schizophrenia Patients." Hospital chronicles = Nosokomeiaka chronika vol. 10,2 (2015): 91-98.
Eugene AR, Masiak J, Kapica J, Masiak M, Weinshilboum RM. Electrophysiological Neuroimaging using sLORETA Comparing 22 Age Matched Male and Female Schizophrenia Patients. Hosp Chron. 2015;10(2):91-98. PMID: 26617679; PMCID: PMC4662405.
Copy Download .nbib Format: NLM
Share it on

Hosp Chron. 2015;10(2):91-98.

Electrophysiological Neuroimaging using sLORETA Comparing 22 Age Matched Male and Female Schizophrenia Patients.

Hospital chronicles = Nosokomeiaka chronika

Andy R Eugene, Jolanta Masiak, Jacek Kapica, Marek Masiak, Richard M Weinshilboum

Affiliations

  1. Department of Molecular Pharmacology and Experimental Therapeutics, Division of Clinical Pharmacology, Gonda 19, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
  2. Department of Psychiatry, Medical University of Lublin, ul. Gluska 1 (SPSK Nr 1), Lublin 20-439, Poland.
  3. Department of Electrical Engineering and Measurement Systems, University of Life Sciences in Lublin, 13 Akademicka Street, Lublin 20-950, Poland.

PMID: 26617679 PMCID: PMC4662405

Abstract

INTRODUCTION: The purpose of this electrophysiological neuroimaging study was to provide a deeper mechanistic understanding of both olanzapine and risperidone pharmacodynamics relative to gender. In doing so, we age-matched 22 men and women and evaluated their resting-state EEG recordings and later used standard low resolution brain Electrotomography to visualize the differences in brain activity amongst the two patient groups.

METHODS: In this investigation, electroencephalogram (EEG) data were analyzed from male and female schizophrenia patients treated with either olanzapine or risperidone, both atypical antipsychotics, during their in-patient stay at the Department of Psychiatry. Twenty-two males and females were age-matched and EEG recordings were analyzed from 19 Ag/AgCl electrodes. Thirty-seconds of resting EEG were spectrally transformed in standardized low resolution electromagnetic tomography (sLORETA). 3D statistical non-paramentric maps for the sLORETA Global Field Power within each band were finally computed.

RESULTS: The results indicated that, relative to males patients, females schizophrenia patients had increased neuronal synchronization in delta frequency, slow-wave, EEG band located in the dorsolateral prefrontal cortex, within the middle frontal gyrus (t= -2.881, p < 0.03580). These findings suggest that females experience greater dopamine (D2) receptor and serotonin (5-HT2) receptor neuronal blockade relative to age-matched males. Further, our finding provided insight to the pharmacodynamics of second-generation antipsychotics olanzapine and risperidone.

CONCLUSION: When compared to male patients, female patients, suffering from schizophrenia, have D2 and 5-HT2 receptors that are blocked more readily than age-matched male schizophrenia patients. Clinically, this may translate into a quicker time to treatment-response in females as compared to male patients.

Keywords: EEG; dopamine; pharmacodynamics; sLORETA; schizophrenia; serotonin

References

  1. Br J Clin Pharmacol. 2001 Apr;51(4):317-24 - PubMed
  2. Biol Psychiatry. 1997 May 15;41(10):1020-7 - PubMed
  3. Clin Pharmacol Ther. 2001 Mar;69(3):89-95 - PubMed
  4. Am J Psychiatry. 2004 Aug;161(8):1324-33 - PubMed
  5. Int J Clin Pharmacol Ther Toxicol. 1980;18(8):362-6 - PubMed
  6. J Cereb Blood Flow Metab. 1996 Jan;16(1):7-22 - PubMed
  7. J Psychiatr Res. 2009 Feb;43(5):497-502 - PubMed
  8. Neuroimage. 2007 Feb 15;34(4):1600-11 - PubMed
  9. Lancet Neurol. 2011 Sep;10(9):829-43 - PubMed
  10. Nat Rev Neurosci. 2002 Mar;3(3):243-9 - PubMed
  11. Neuropsychobiology. 2007;55(3-4):132-42 - PubMed
  12. Clin Neurophysiol. 2002 May;113(5):702-12 - PubMed
  13. Int J Psychophysiol. 1994 Oct;18(1):49-65 - PubMed
  14. Am J Psychiatry. 1999 Feb;156(2):286-93 - PubMed
  15. Psychophysiology. 1994 Jan;31(1):37-43 - PubMed
  16. Pharmakopsychiatr Neuropsychopharmakol. 1979 Mar;12(2):237-45 - PubMed
  17. Harv Rev Psychiatry. 1994 Nov-Dec;2(4):204-13 - PubMed
  18. Clin Neurophysiol. 2001 Apr;112(4):713-9 - PubMed
  19. Biol Psychiatry. 1987 Aug;22(8):1021-4 - PubMed
  20. Electroencephalogr Clin Neurophysiol. 1993 Jan;86(1):1-6 - PubMed
  21. Biol Psychiatry. 2006 Jul 1;60(1):11-21 - PubMed
  22. JAMA Psychiatry. 2015 Jan;72(1):5-13 - PubMed
  23. Schizophr Res. 2001 Mar 30;48(2-3):207-17 - PubMed
  24. Am J Psychiatry. 1998 Jul;155(7):921-8 - PubMed
  25. Ann Neurol. 1990 Dec;28(6):811-7 - PubMed
  26. Biol Psychiatry. 1994 Dec 15;36(12):801-26 - PubMed
  27. Psychiatry Res. 1999 Jun 30;90(3):169-79 - PubMed
  28. Philos Trans R Soc Lond B Biol Sci. 2001 Aug 29;356(1412):1293-322 - PubMed
  29. Methods Find Exp Clin Pharmacol. 2002;24 Suppl D:5-12 - PubMed
  30. Arq Neuropsiquiatr. 2003 Sep;61(3B):712-7 - PubMed
  31. Neurosci Res. 2011 Aug;70(4):442-8 - PubMed

Publication Types

Grant support